Injectable atypical antipsychotics for agitation in borderline personality disorder: A case report

J. C. Pascual, M. Madre, J. Soler, J. Barrachina, M. J. Campins, E. Alvarez, Victor Perez

Research output: Contribution to journalArticleResearchpeer-review

24 Citations (Scopus)

Abstract

Agitation is relatively common among Borderline Personality Disorder (BPD) patients in Psychiatric Emergency Services (PES). New injectable atypical antipsychotics are indicated for treatment in agitated psychotic or maniac patients but not for agitated BDP patients. Twenty agitated BPD patients were treated with intramuscular atypical antipsychotics (olanzapine or ziprasidone). Results suggest intramuscular atypical antipsychotics may be effective, fast and safe for treating acute BPD patients. © Georg Thieme Verlag KG Stuttgart.
Original languageEnglish
Pages (from-to)117-118
JournalPharmacopsychiatry
Volume39
Issue number3
DOIs
Publication statusPublished - 1 May 2006

Fingerprint Dive into the research topics of 'Injectable atypical antipsychotics for agitation in borderline personality disorder: A case report'. Together they form a unique fingerprint.

Cite this